Helius Medical Technologies, based in Newtown, Pennsylvania, focuses on neurological wellness and went public on June 27, 2014. Their product, PoNS, is a non-implantable device that treats gait and balance deficits.
Helius Medical Technologies (HSDT) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Helius Medical Technologies's actual EPS was -$0.99, beating the estimate of -$1.08 per share, resulting in a 8.44% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
